Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock Holdings Decreased by Covenant Asset Management LLC

Covenant Asset Management LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 10,907 shares of the medical equipment provider’s stock after selling 183 shares during the period. Intuitive Surgical comprises about 0.9% of Covenant Asset Management LLC’s investment portfolio, making the stock its 16th biggest holding. Covenant Asset Management LLC’s holdings in Intuitive Surgical were worth $5,693,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. boosted its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter valued at about $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at approximately $38,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $595.55 on Friday. The stock has a fifty day moving average of $558.58 and a 200-day moving average of $518.00. The stock has a market capitalization of $212.12 billion, a P/E ratio of 92.91, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insiders Place Their Bets

In related news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the company’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 6,348 shares of company stock valued at $3,587,582. 0.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent analyst reports. Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Piper Sandler restated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Finally, UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.